

![]() |
Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials |
|
Authors | ||
Published in | Journal of Clinical Psychopharmacology. 2019, vol. 39, no. 6, p. 658-664 | |
Abstract | The negative symptoms of schizophrenia pose a heavy burden on patients and relatives and represent an unmet therapeutic need. The observed association of negative symptoms with impaired reward system function has stimulated research on prodopaminergic agents as potential adjunctive treatments. | |
Keywords | Prodopaminergic — Stimulants — Schizophrenia — Negative symptoms — Amotivation | |
Identifiers | PMID: 31688399 | |
Full text | ||
Structures | ||
Research group | Psychopathologie clinique et expérimentale (987) | |
Citation (ISO format) | SABE, Michel, KIRSCHNER, Matthias, KAISER, Stefan. Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials. In: Journal of Clinical Psychopharmacology, 2019, vol. 39, n° 6, p. 658-664. doi: 10.1097/JCP.0000000000001124 https://archive-ouverte.unige.ch/unige:132681 |